| 1 |
34964415 | Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review. | 2022 May |
1 |
| 2 |
26358483 | [Vortioxetine: a new antidepressant to treat depressive episodes]. | 2016 Feb |
1 |
| 3 |
26879252 | [Pharmacological properties of vortioxetine and its pre-clinical consequences]. | 2016 Feb |
1 |
| 4 |
25831967 | Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors). | 2015 Apr |
1 |
| 5 |
24311349 | Vortioxetine: first global approval. | 2014 Jan |
1 |
| 6 |
25166025 | Vortioxetine for the treatment of major depressive disorder. | 2014 Nov |
3 |
| 7 |
25418918 | The efficacy of vortioxetine for the treatment of major depressive disorder. | 2014 Dec |
1 |
| 8 |
25717481 | [Cognitive dysfunctions in depression - underestimated symptom or new dimension?]. | 2014 Nov-Dec |
1 |